MECR and Parkinson disease: Since MECR mutations can lead to mitochondrial dysfunction and neurodegeneration [19,20,21], and our transcriptomic analysis (microarray and scRNA-seq) has shown decreased MECR expression in PD, we aimed to screen for potential allosteric activators of MECR as candidates for further investigation in PD.